LSI

EQS-News: TVM CAPITAL LIFE SCIENCE TO PARTICIPATE IN LSI USA ’24 EMERGING MEDTECH SUMMIT 2024

Retrieved on: 
Wednesday, April 10, 2024
Radiation, Thrombosis, Partner (business rank), Infection, Intelligence, TVM, Risk, General partnership, Patient, Eye injury, Standard of care, AI, Workflow, Investment, LSI, Phlebitis, Eli Lilly and Company, Vector, Therapy, FDA, Physician, Health, PFC, Medical imaging

Munich, Germany and Montreal, Quebec, Canada (March 13, 2024) – TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences innovation, today announced that the Company will participate in the sixth annual LSI USA ’24 Emerging Medtech Summit 2024, which brings together leading innovators, active investors and committed strategics from the medtech industry to partner and build next-generation healthcare technologies.

Key Points: 
  • Munich, Germany and Montreal, Quebec, Canada (March 13, 2024) – TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences innovation, today announced that the Company will participate in the sixth annual LSI USA ’24 Emerging Medtech Summit 2024, which brings together leading innovators, active investors and committed strategics from the medtech industry to partner and build next-generation healthcare technologies.
  • The conference will take place March 18-22, 2024, in Dana Point, California, USA.
  • "Medtech innovation continues to be at the forefront of healthcare advancement, driving transformative changes in patient care, operational efficiency and cost reduction.
  • As part of our commercial-stage medical technologies investment strategy, TVM seeks breakthrough solutions that align with emerging trends and could redefine the standard of care.

TVM Capital Life Science to Participate in LSI USA ’24 Emerging Medtech Summit 2024

Retrieved on: 
Wednesday, March 13, 2024
Radiation, Thrombosis, Partner (business rank), Infection, Intelligence, TVM, Risk, General partnership, Patient, Eye injury, Standard of care, AI, Workflow, Investment, Medtech, LSI, Phlebitis, Eli Lilly and Company, Vector, Therapy, FDA, Physician, Health, PFC, Medical imaging

MUNICH, Germany and MONTREAL, March 13, 2024 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences innovation, today announced that the Company will participate in the sixth annual LSI USA ’24 Emerging Medtech Summit 2024, which brings together leading innovators, active investors and committed strategics from the medtech industry to partner and build next-generation healthcare technologies.

Key Points: 
  • MUNICH, Germany and MONTREAL, March 13, 2024 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences innovation, today announced that the Company will participate in the sixth annual LSI USA ’24 Emerging Medtech Summit 2024, which brings together leading innovators, active investors and committed strategics from the medtech industry to partner and build next-generation healthcare technologies.
  • The conference will take place March 18-22, 2024, in Dana Point, California, USA.
  • “Medtech innovation continues to be at the forefront of healthcare advancement, driving transformative changes in patient care, operational efficiency and cost reduction.
  • As part of our commercial-stage medical technologies investment strategy, TVM seeks breakthrough solutions that align with emerging trends and could redefine the standard of care.

THine Releases to Launch AI Server Business in Addition to LSI and AIOT Business

Retrieved on: 
Monday, March 18, 2024
Other Manufacturing, Mobile, Wireless, Technology, Semiconductor, Software, Manufacturing, Hardware, Data Management, IOT (Internet of Things), Artificial Intelligence, THine Electronics, Research, Fujitsu, AI, Hyperdata, Electronics, Thou, LSI, Tokyo Stock Exchange

THine Electronics, Inc. (Tokyo Stock Exchange: 6769, “THine”), the global leader in high-speed serial interface and provider of mixed-signal LSI as well as valuable AI/IoT-based solution, today releases to launch its data server business to enhance its business synergy and efficiency in addition to its semiconductor and AI/IoT business.

Key Points: 
  • THine Electronics, Inc. (Tokyo Stock Exchange: 6769, “THine”), the global leader in high-speed serial interface and provider of mixed-signal LSI as well as valuable AI/IoT-based solution, today releases to launch its data server business to enhance its business synergy and efficiency in addition to its semiconductor and AI/IoT business.
  • In order to contribute to further utilization of generative AI and AI research in Japan, THine has decided to provide data servers, including AI servers equipped with NVIDIA’s GPUs.
  • THine’s new server business will provide:
    and develop software, systems and solutions related to the above, etc.
  • THine plans to establish its new subsidiary, THine HyperData, Inc., on April 1st, 2024 in Yokohama, Japan with the following representatives:
    Chairman and CEO: Takashi Nakahara, the board member of THine, and the Founder and CEO of THine’s AIOT subsidiary
    President: Kenji Mizuno, the President of Fujitsu Isotec Limited until March 31st, 2024
    “It is our great pleasure to support and accelerate the AI utilization and AI research in Japan,” said Dr. Takashi Nakahara, Chief Architect Officer of THine, “THine HyperData plans to achieve its sales of 1 billion yen or more in FY2028, accelerating its business by collaboration just like THine’s AIOT business does.”

Endologix to Present at Upcoming LSI US ’24 Emerging Medtech Summit

Retrieved on: 
Thursday, March 14, 2024
Medical Devices, Health, Other Science, General Health, Research, Science, Vascular disease, LSI, Pharmaceutical industry

Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, today announced that Matt Thompson, President and CEO, will present at the Life Science Intelligence (LSI) USA '24 Emerging Medtech Summit.

Key Points: 
  • Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, today announced that Matt Thompson, President and CEO, will present at the Life Science Intelligence (LSI) USA '24 Emerging Medtech Summit.
  • Scheduled for March 20, 2024, at 10:55 am PT on Track 3, Thompson will offer insights into the company's innovative portfolio and its impact on vascular disease treatment.
  • Matt Thompson remarked, "At this pivotal juncture for Endologix, our involvement in the LSI US '24 Emerging Medtech Summit underscores our dedication to spearheading innovation in vascular disease.
  • The summit represents a unique platform for interaction with industry peers and thought leaders, enabling collaborations that are essential for shaping the future of healthcare."

Accelus President & CEO Kevin McGann to Present at LSI USA '24 Conference

Retrieved on: 
Tuesday, March 5, 2024
PALM, Spinal fusion, Chris Chaney, LSI, Adaptation, Surgeon, Sale, Patient, BEACH, Knowledge, Capital

McGann’s presentation will provide an unparalleled opportunity for industry participants to engage with the company.

Key Points: 
  • McGann’s presentation will provide an unparalleled opportunity for industry participants to engage with the company.
  • Accelus has made significant strides under McGann’s leadership, from the sale of its Remi spine robot to Alphatec for $55 million to its recent $20 million funding from Symbiotic Capital.
  • “The LSI USA ’24 conference presents a valuable opportunity for attendees to discover how Accelus’s advancements in expandable spinal implants are providing minimally invasive yet maximally effective solutions for spinal fusion,” McGann said.
  • Attendees of the LSI USA '24 conference are invited to join Kevin McGann's presentation on March 21st at 2:40 p.m. in Track 2 to learn more about Accelus's transformative technologies and strategic vision for the future of spine care.

Caira Surgical to Showcase Radar Surgical Tracking Technology at LSI USA '24 Emerging Medtech Summit

Retrieved on: 
Tuesday, February 20, 2024
Caira, LSI, Shoulder, FDA, Surgeon, Instrument, Waldorf Astoria New York, Patient safety, Hip, Medical device

NEW YORK, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Caira Surgical, the pioneer in Radar Surgical Tracking for robotic and navigated joint replacement surgery, today announced its upcoming participation in the prestigious LSI USA '24 Emerging Medtech Summit.

Key Points: 
  • NEW YORK, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Caira Surgical, the pioneer in Radar Surgical Tracking for robotic and navigated joint replacement surgery, today announced its upcoming participation in the prestigious LSI USA '24 Emerging Medtech Summit.
  • “We are proud to be back at the LSI USA Emerging Medtech Summit this year to showcase our technology and the milestones we have made as we prepare to file for FDA clearance later this year,” Greenwald said.
  • In addition to showcasing its radar surgical tracking system for knee replacement procedures, Caira Surgical plans to expand into hip, shoulder, and spine procedures, further broadening the impact of its innovative technology.
  • Caira Surgical invites attendees of the LSI USA '24 Emerging Medtech Summit to join Jon Greenwald's presentation and learn more about the company's pioneering technologies and strategic vision.

LSI Announces the Retirement of President & Chief Executive Officer, Sean M. Slatter, March 4, 2024

Retrieved on: 
Monday, March 4, 2024
Consulting, Professional Services, Transport, Logistics, Supply Chain Management, Bertagnolli, Culture, Slatter, Human, Economic development, Fortune 500, LSI, Former, Multimedia, COVID, Management

LSI has announced that Sarah Bertagnolli has been promoted to President and CEO effective March 4, 2024.

Key Points: 
  • LSI has announced that Sarah Bertagnolli has been promoted to President and CEO effective March 4, 2024.
  • Sean Slatter, who has served as LSI’s CEO since 1992, will continue to serve as LSI’s Board Chair.
  • View the full release here: https://www.businesswire.com/news/home/20240304961405/en/
    Sean Slatter, Former President & CEO of LSI, served for 32 Years.
  • Since its founding in 1972, LSI has been a trusted resource to Fortune 500 companies, federal, state, and municipal entities.

JSI Store Fixtures Launches New Line of Environmentally Friendly Refrigerated Displays

Retrieved on: 
Tuesday, February 27, 2024
Other Retail, Manufacturing, Supermarket, HVAC, Food, Beverage, Other Manufacturing, Green Technology, Retail, Environment, Machinery, Sustainability, HFC, JSI, LSI, Multimedia, Hydrofluorocarbon, Research, SNAP, Chlorofluorocarbon, GWP, Renewable energy

JSI Store Fixtures, an LSI Industries Inc. company (Nasdaq: LYTS), shipped its first order of refrigerated retail displays featuring environmentally friendly R290 refrigerant this month.

Key Points: 
  • JSI Store Fixtures, an LSI Industries Inc. company (Nasdaq: LYTS), shipped its first order of refrigerated retail displays featuring environmentally friendly R290 refrigerant this month.
  • JSI was well positioned to implement this new method in its store fixtures and to provide customers with an exciting, innovative, and environmentally sound solution to improve the environment.
  • JSI is committed to transitioning away from CFCs, HCFCs and HFCs to more environmentally friendly natural refrigerants such as R290 propane.
  • JSI established a new manufacturing site for research and development of next generation, environmentally friendly products to continue innovating industry-leading solutions.

Muse Microscopy, Inc. to Present SmartPath MUSE Technology™ (SmartPath) at Upcoming Emerging Medtech Summit (LSI USA '24) in Dana Point, CA

Retrieved on: 
Wednesday, March 6, 2024
Pathology, Health, LSI, AI

Larry Dentice, the President and Director of Muse Microscopy, Inc., will present on March 21 at 10:45 am, Track 3, at LSI USA '24.

Key Points: 
  • Larry Dentice, the President and Director of Muse Microscopy, Inc., will present on March 21 at 10:45 am, Track 3, at LSI USA '24.
  • The presentation will focus on the future of direct-to-digital imaging using our SmartPath MUSE Technology™ (SmartPath) instrument.
  • As a leader in innovative MUSE technology, we aim to revolutionize patient and pathology experiences by generating high-quality direct-to-digital images in minutes.
  • For more information about the LSI USA '24 event, including registration details, please visit official event website at Emerging Medtech Summit 2024 - Life Science Intelligence (lifesciencemarketresearch.com)

As Housing Starts Improve, Lot Supply Tightens Again, Zonda Reports

Retrieved on: 
Thursday, February 8, 2024
Index, Classification, Growth, LSI, Housing, Real estate

NEWPORT BEACH, Calif., Feb. 8, 2024 /PRNewswire-PRWeb/ -- Today, the experts at Zonda, the housing industry's foremost advisors, released the New Home Lot Supply Index (LSI) for 4Q23. The New Home LSI, backed by data from Zonda, showed lot supply loosened year-over-year across the United States, but tightened quarter-over-quarter. The index is a residential real estate indicator based on the number of single-family vacant developed lots and the rate at which those lots are absorbed via housing starts.

Key Points: 
  • NEWPORT BEACH, Calif., Feb. 8, 2024 /PRNewswire-PRWeb/ -- Today, the experts at Zonda , the housing industry's foremost advisors, released the New Home Lot Supply Index (LSI) for 4Q23.
  • The New Home LSI, backed by data from Zonda, showed lot supply loosened year-over-year across the United States, but tightened quarter-over-quarter.
  • We consider the total vacant developed lot supply and adjust it for overall starts activity.
  • It is necessary to monitor residential lot supply to understand how new home markets may be impacted by the incoming pipeline.